Medifirst Solutions Inc. updated shareholders regarding its new stage of operations. As recently announced, Medifirst Solutions Inc., in response to its Premarket Notification 510(k) submission, received clearance from the U.S. Food and Drug Administration (FDA) to market its infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device. As part of the pre-sales and marketing rollout of the Laser Series, Medifirst has begun to implement internal controls and procedures as mandated by the FDA. These controls and procedures include in-office checks and balances, as well as those required at its manufacturer, and must be implemented prior to initiating sales. The company is aggressively putting together a sales &distribution team to offer its lasers in the US market. The team will be made up of seasoned professionals with experience in the sales and marketing of medical devices that will initially focus on targeting and analyzing the specific markets and sectors to which to market its products. Additionally, as part of a corporate restructure the company will be appointing Board Members with well-established credentials in the medical device Industry as well as established and renowned industry professionals from the business and financial community. Medifirst has plans to add a CFO and additional officers to its corporate operations.